Showing results (161-170 of 201) with videos related to

Sort By:
Pageof 21
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 positionBrian A Johns, Jason G Weatherhead, Scott H Allen, et al.
The Journal of Biological Chemistry|October 28, 1994
Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureasE P Garvey, J A Oplinger, G J Tanoury, et al.
Antimicrobial Agents and Chemotherapy|September 16, 2015
VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Nathan P Wiederhold, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161Andrew T Nishimoto, Sarah G Whaley, Nathan P Wiederhold, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2017
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Sondus Alkhazraji, Lin Lin, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human EnzymeAndrew G S Warrilow, Josie E Parker, Claire L Price, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2012
Naphthyridinone (NTD) integrase inhibitors: N1 protio and methyl combination substituent effects with C3 amide groupsBrian A Johns, Takashi Kawasuji, Jason G Weatherhead, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2014
Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groupsBrian A Johns, Takashi Kawasuji, Jason G Weatherhead, et al.
Pageof 21